1-[4-(8-CHLORO-5H-DIBENZO-[B,E]-[1,4]-DIAZEPIN-11-YL)-1-METHYLHEXAHYDROPYRAZIN-1-IUM]-1-(4-PHENYL)-BUTANIMIDE
Compound with spectra: 1 NMR
![1-[4-(8-CHLORO-5H-DIBENZO-[B,E]-[1,4]-DIAZEPIN-11-YL)-1-METHYLHEXAHYDROPYRAZIN-1-IUM]-1-(4-PHENYL)-BUTANIMIDE](/api/compound/IfMpMQKoAa1.png?ph=true&h=300&w=458 "1-[4-(8-CHLORO-5H-DIBENZO-[B,E]-[1,4]-DIAZEPIN-11-YL)-1-METHYLHEXAHYDROPYRAZIN-1-IUM]-1-(4-PHENYL)-BUTANIMIDE")
| SpectraBase Compound ID | IfMpMQKoAa1 |
|---|---|
| InChI | InChI=1S/C28H30ClN5O/c1-34(32-27(35)13-7-10-21-8-3-2-4-9-21)18-16-33(17-19-34)28-23-11-5-6-12-24(23)30-25-15-14-22(29)20-26(25)31-28/h2-6,8-9,11-12,14-15,20,30H,7,10,13,16-19H2,1H3 |
| InChIKey | ZEXANTJVOZDOIB-UHFFFAOYSA-N |
| Mol Weight | 488.04 g/mol |
| Molecular Formula | C28H30ClN5O |
| Exact Mass | 487.213888 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
1-[4-(8-CHLORO-5H-DIBENZO-[B,E]-[1,4]-DIAZEPIN-11-YL)-1-METHYLHEXAHYDROPYRAZIN-1-IUM]-1-(6-PHENYL)-HEXANIMIDE
1-[4-(8-CHLORO-5H-DIBENZO-[B,E]-[1,4]-DIAZEPIN-11-YL)-1-METHYLHEXAHYDROPYRAZIN-1-IUM]-1-(5-PHENYL)-PENTANIMIDE
1-[4-(8-CHLORO-5H-DIBENZO-[B,E]-[1,4]-DIAZEPIN-11-YL)-1-METHYLHEXAHYDROPYRAZIN-1-IUM]-1-(10-PHENYL)-DECANIMIDE
1-[4-(8-CHLORO-5H-DIBENZO-[B,E]-[1,4]-DIAZEPIN-11-YL)-1-METHYLHEXAHYDROPYRAZIN-1-IUM]-1-(3-PHENYL)-PROPANIMIDE
1-[4-(8-CHLORO-5H-DIBENZO-[B,E]-[1,4]-DIAZEPIN-11-YL)-1-METHYLHEXAHYDROPYRAZIN-1-IUM]-2-(PHENYL)-ACETIMIDE
Clozapine-M (7 OH)
Clozapine-M (6 OH)
Clozapine ME
(12-N-Methyl)-11-(o-methylaniline)-5H-dibenzo[b,e][1,4]diazepines
(12-N-Methyl)-11-(o-bromoaniline)-5H-dibenzo[b,e][1,4]diazepines
| Title | Journal or Book | Year |
|---|---|---|
| Aminimides as Potential CNS Acting Agents. II Design, Synthesis, and Receptor Binding of 4′-Arylalkyl Aminimide Analogues of Clozapine as Prospective Novel Antipsychotics | Australian Journal of Chemistry | 2008 |